• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦鳞状细胞癌的表现与预后:全国视角

Sinonasal Squamous Cell Carcinoma Presentation and Outcome: A National Perspective.

作者信息

Al-Qurayshi Zaid, Smith Ryan, Walsh Jarrett E

机构信息

Department of Otolaryngology - Head & Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

出版信息

Ann Otol Rhinol Laryngol. 2020 Nov;129(11):1049-1055. doi: 10.1177/0003489420929048. Epub 2020 May 31.

DOI:10.1177/0003489420929048
PMID:32476435
Abstract

BACKGROUND

examine presentation and outcomes of sinonasal squamous cell carcinoma (SCC).

METHODS

A retrospective study utilizing the National Cancer Database, 2004 to 2015. The study population included adult patients diagnosed with primary sinonasal SCC.

RESULTS

A total of 537 patients were included. The mean age of the study population was 62.6 ± 12.7 years. The median follow-up time was 35.6 months (interquartile range: 8.6-55.9). The histological variants identified are: (i) 66.7% keratinizing SCC, (ii) 21.6% non-keratinizing SCC, (iii) 8.0% papillary SCC, and (iv) 3.7% spindle cell carcinoma. Stage at presentation was: (i) 33.3% T1-2, N0, (ii) 31.8% T3-4a, N0, (iii) 13.8% T1-4a, N+, (iv) 17.0% T4b,N0-3, (v) 4.1% M1. Human papilloma virus (HPV) status was available for 96 patients and tested positive in 24 (25.0%) patients. By histological variants, 5-year survival was lowest for spindle cell carcinoma (40.0%), and highest for papillary SCC (70.1%). HPV negative tumors had a 5-year survival of 26.4%, while HPV positive tumors had a 5-year survival of 57.1% ( = <.001). Of the 255 patients with T1-4a, N0-3, M0 who had surgery of the primary site, 31 (12.2%) patients underwent endoscopic approach. The risk of positive postsurgical margins was not significantly different comparing endoscopic to open approach (23.8% vs 24.1%, >.99).

CONCLUSIONS

Sinonasal SCC could present at advanced stages in two-thirds of the population and exhibit a variety of histological subtypes. Like other sites of head and neck, HPV positive tumors are associated with a favorable prognosis. Endoscopic approach is comparable to open approach in terms of post-surgical margins.

摘要

背景

研究鼻窦鳞状细胞癌(SCC)的临床表现及预后。

方法

利用国家癌症数据库进行一项回顾性研究,时间跨度为2004年至2015年。研究人群包括诊断为原发性鼻窦SCC的成年患者。

结果

共纳入537例患者。研究人群的平均年龄为62.6±12.7岁。中位随访时间为35.6个月(四分位间距:8.6 - 55.9)。确定的组织学亚型为:(i)66.7%角化型SCC,(ii)21.6%非角化型SCC,(iii)8.0%乳头状SCC,以及(iv)3.7%梭形细胞癌。就诊时的分期为:(i)33.3% T1 - 2,N0,(ii)31.8% T3 - 4a,N0,(iii)13.8% T1 - 4a,N +,(iv)17.0% T4b,N0 - 3,(v)4.1% M1。96例患者可获得人乳头瘤病毒(HPV)状态,其中24例(25.0%)检测呈阳性。按组织学亚型,梭形细胞癌的5年生存率最低(40.0%),乳头状SCC最高(70.1%)。HPV阴性肿瘤的5年生存率为26.4%,而HPV阳性肿瘤为57.1%(P = <.001)。在255例T1 - 4a,N0 - 3,M0且接受原发部位手术的患者中,31例(12.2%)采用了内镜手术入路。内镜手术与开放手术相比,术后切缘阳性风险无显著差异(23.8%对24.1%,P >.99)。

结论

三分之二的鼻窦SCC患者就诊时处于晚期,且表现出多种组织学亚型。与头颈部其他部位一样,HPV阳性肿瘤预后较好。在内镜手术切缘方面,内镜手术入路与开放手术相当。

相似文献

1
Sinonasal Squamous Cell Carcinoma Presentation and Outcome: A National Perspective.鼻窦鳞状细胞癌的表现与预后:全国视角
Ann Otol Rhinol Laryngol. 2020 Nov;129(11):1049-1055. doi: 10.1177/0003489420929048. Epub 2020 May 31.
2
Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma.人乳头瘤病毒阳性在鼻窦鳞状细胞癌中的意义。
Int Forum Allergy Rhinol. 2017 Oct;7(10):980-989. doi: 10.1002/alr.21996. Epub 2017 Aug 31.
3
Survival outcomes after endoscopic resection for sinonasal squamous cell carcinoma arising on inverted papilloma.鼻内翻性乳头状瘤伴发的鼻窦鳞状细胞癌经内镜切除后的生存结果。
Head Neck. 2016 Nov;38(11):1604-1614. doi: 10.1002/hed.24481. Epub 2016 May 6.
4
Sinonasal squamous cell carcinoma and the prognostic implications of its histologic variants: a population-based study.鼻腔鼻窦鳞状细胞癌及其组织学变异型的预后意义:一项基于人群的研究。
Int Forum Allergy Rhinol. 2015 Jan;5(1):85-91. doi: 10.1002/alr.21418. Epub 2014 Oct 2.
5
Sinonasal malignancy: presentation and outcomes.鼻窦恶性肿瘤:临床表现与治疗结果
J Laryngol Otol. 2014 Jul;128(7):654-7. doi: 10.1017/S0022215114001066.
6
Endoscopic Versus Open Resection of Non-Squamous Cell Carcinoma Sinonasal Malignancies.内镜与开放手术切除非鳞状细胞鼻窦恶性肿瘤的比较。
Laryngoscope. 2020 Aug;130(8):1872-1876. doi: 10.1002/lary.28270. Epub 2019 Sep 12.
7
The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma.选择性颈清扫术在上颌窦鳞状细胞癌治疗中的作用。
Laryngoscope. 2018 Aug;128(8):1835-1841. doi: 10.1002/lary.27009. Epub 2017 Nov 29.
8
The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma.内镜切除术在选择的鼻窦鳞状细胞癌患者中的作用。
Auris Nasus Larynx. 2021 Feb;48(1):131-137. doi: 10.1016/j.anl.2020.06.014. Epub 2020 Jul 25.
9
Survival Outcomes in Sinonasal Poorly Differentiated Squamous Cell Carcinoma.鼻腔鼻窦低分化鳞状细胞癌的生存结果。
Laryngoscope. 2021 Apr;131(4):E1040-E1048. doi: 10.1002/lary.29090. Epub 2020 Sep 22.
10
Squamous cell carcinoma of the maxillary sinus: A population-based analysis.上颌窦鳞状细胞癌:一项基于人群的分析。
Laryngoscope. 2016 Feb;126(2):399-404. doi: 10.1002/lary.25601. Epub 2015 Sep 22.

引用本文的文献

1
Prognostic impact of peripheral blood ratio in sinonasal squamous cell carcinoma.外周血比值在鼻窦鳞状细胞癌中的预后影响
Sci Prog. 2025 Jul-Sep;108(3):368504251364321. doi: 10.1177/00368504251364321. Epub 2025 Jul 29.
2
Nodal metastasis in surgically treated sinonasal squamous cell carcinoma.手术治疗的鼻窦鳞状细胞癌中的淋巴结转移
Discov Oncol. 2025 Jul 14;16(1):1328. doi: 10.1007/s12672-025-02899-0.
3
Sinonasal Carcinoma With Aggressive Right Intraorbital Extension and Left Eye Invasion in a Young Female Patient.一名年轻女性患者患有伴右侧眼眶内侵袭性扩展及左眼侵犯的鼻窦癌。
Cureus. 2024 Nov 20;16(11):e74066. doi: 10.7759/cureus.74066. eCollection 2024 Nov.
4
Surgical resection and overall survival in cT4b sinonasal non-squamous cell carcinoma.cT4b期鼻窦非鳞状细胞癌的手术切除与总生存期
Laryngoscope Investig Otolaryngol. 2024 Oct 23;9(5):e70025. doi: 10.1002/lio2.70025. eCollection 2024 Oct.
5
Sinonasal Squamous Cell Carcinoma in the Netherlands: A Population-Based Study of 568 Cases Diagnosed in 2008-2021.荷兰的鼻窦鳞状细胞癌:一项基于人群的研究,涉及2008年至2021年确诊的568例病例
Head Neck. 2025 Feb;47(2):695-705. doi: 10.1002/hed.27961. Epub 2024 Oct 16.
6
Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma.鼻窦鳞状细胞癌患者拒绝术后放疗的决定因素
J Neurol Surg B Skull Base. 2022 Jun 6;84(3):232-239. doi: 10.1055/a-1780-4157. eCollection 2023 Jun.
7
Human Papillomavirus-Related Carcinomas of the Sinonasal Tract.人乳头瘤病毒相关的鼻窦癌
Curr Otorhinolaryngol Rep. 2022 Sep;10:291-302. doi: 10.1007/s40136-022-00404-7. Epub 2022 May 11.
8
Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma.评估新型生存标志物在鼻腔鼻窦鳞状细胞癌患者中的预后能力。
Nutrients. 2022 Oct 17;14(20):4337. doi: 10.3390/nu14204337.
9
A Clinical-Radiomics Nomogram Based on the Apparent Diffusion Coefficient (ADC) for Individualized Prediction of the Risk of Early Relapse in Advanced Sinonasal Squamous Cell Carcinoma: A 2-Year Follow-Up Study.基于表观扩散系数(ADC)的临床-影像组学列线图用于个体化预测晚期鼻窦鳞状细胞癌早期复发风险:一项2年随访研究
Front Oncol. 2022 May 16;12:870935. doi: 10.3389/fonc.2022.870935. eCollection 2022.
10
MiR-654-3p Constrains Proliferation, Invasion, and Migration of Sinonasal Squamous Cell Carcinoma CREB1/PSEN1 Regulatory Axis.微小RNA-654-3p通过CREB1/PSEN1调控轴抑制鼻窦鳞状细胞癌的增殖、侵袭和迁移。
Front Genet. 2022 Jan 12;12:799933. doi: 10.3389/fgene.2021.799933. eCollection 2021.